Scarica l'app Stockscreener
110.16
2.83%
-3.21
Corcept Therapeutics Inc Azioni (CORT) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
55.33%
256.15
|
164.90 | 202.12 | 207.64 | 194.43 |
| Cost Of Revenue |
40.86%
4.061
|
2.883 | 2.545 | 4.596 | 3.433 |
Selling, General, and Administrative
|
7.94%
156.90
|
145.36 | 130.24 | - | - |
| Costs And Expenses |
0.16%
214.85
|
214.50 | 197.64 | 197.42 | 167.75 |
| Operating Income/Loss |
183.26%
41.30
|
-49.60 | 4.487 | 10.22 | 26.68 |
| Nonoperating Income/Loss |
5.22%
4.631
|
4.886 | 5.423 | 5.024 | 5.017 |
| Income/Loss From Continuing Operations Before Tax |
202.72%
45.93
|
-44.72 | 9.91 | 15.24 | 31.69 |
| Income Tax Expense/Benefit, Deferred |
121.98%
2.881
|
-13.11 | -15.18 | 9.114 | -17.76 |
| Income Tax Expense/Benefit |
122.73%
2.944
|
-12.95 | -14.38 | -4.425 | -3.457 |
|
Net Income/Loss
|
235.35%
42.99
|
-31.76 | 24.29 | 19.67 | 35.15 |
| Basic Average Shares |
0.90%
105.38
|
104.44 | - | 103.55 | 104.11 |
| Diluted Average Shares |
13.36%
118.39
|
104.44 | - | 119.44 | 120.48 |
| Basic Earnings Per Share |
233.33%
0.40
|
-0.30 | - | 0.19 | 0.33 |
| Diluted Earnings Per Share |
220.00%
0.36
|
-0.30 | - | 0.16 | 0.29 |
4.81%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):